Balili, John P.

HRN: 27-35-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/20/2025
06/26/2025
IV
1.5g
Q6h
Inflamed Foot With Abscess
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: